Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei — A combined MRI and H2 15O PET study

The anorexigenic gastrointestinal hormone Peptide YY plays an important role in the communication between the gastrointestinal tract and the central nervous system. PYY has been shown to modulate brain activity in regions implicated in reward and food related behavior. Its effects on brain structure however, remain unknown. Voxel-based morphometry was used to investigate the relationship between fasting and postprandial plasma PYY concentrations and regional gray matter volume (GMV). For this analysis twenty adult, non diabetic Caucasians were included (18F/2M, age 31±9 y, percentage of body fat [PFAT] 32±8%) who had volumetric brain magnetic resonance images and underwent H(2)(15)O positron emission tomographic (PET) measurements of regional cerebral blood flow (rCBF), a marker of local neuronal activity, and measurements of plasma total PYY, prior to (fasting) and following a satiating liquid meal. Voxel-wise analysis revealed a regional positive association between postprandial PYY and gray matter volume bilaterally in the caudate nuclei. These associations remained significant (p<0.05) after small volume correction for multiple comparisons. Based on these findings we investigated whether postprandial PYY is associated with PET measured rCBF of the caudate nucleus. We found a significant negative association between average postprandial caudate rCBF and postprandial plasma PYY concentrations (r=-0.60, p<0.02, age, sex and PFAT adjusted). Average postprandial caudate rCBF was also negatively associated with rCBF in the right medial orbitofrontal cortex and the right hippocampal formation (p<0.05, corrected for multiple comparisons). Total PYY is positively associated with gray matter but negatively with postprandial activity in the caudate nuclei while caudate activity is negatively associated with rCBF in prefrontal and paralimbic regions implicated in reward behavior. Thus, PYY may act centrally to modulate eating behavior via striatal networks.

[1]  Lori Haase,et al.  Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults , 2011, Brain Research.

[2]  Kewei Chen,et al.  Relationships between plasma leptin concentrations and human brain structure: A voxel-based morphometric study , 2007, Neuroscience Letters.

[3]  J. Holst,et al.  Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man , 2009, Regulatory Peptides.

[4]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[5]  Udi E. Ghitza,et al.  Peptide YY3-36 Decreases Reinstatement of High-Fat Food Seeking during Dieting in a Rat Relapse Model , 2007, The Journal of Neuroscience.

[6]  Yu-Shin Ding,et al.  Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors , 2008, NeuroImage.

[7]  E. Rolls,et al.  The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology , 2004, Progress in Neurobiology.

[8]  Wei Zhang,et al.  The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis , 2009, BMC public health.

[9]  D. Gehlert,et al.  Multiple Receptors for the Pancreatic Polypeptide (PP-Fold) Family: Physiological Implications , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[11]  F. Middleton,et al.  Weight regain after Roux-en-Y: a significant 20% complication related to PYY. , 2008, Nutrition.

[12]  A. Astrup,et al.  The reproducibility of subjective appetite scores , 1995, British Journal of Nutrition.

[13]  Birgitte Sloth,et al.  Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. , 2007, American journal of physiology. Endocrinology and metabolism.

[14]  Stephen R. Bloom,et al.  Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3–36) on food intake , 2005, Brain Research.

[15]  Bruno Giordani,et al.  Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease , 1999, Biological Psychiatry.

[16]  R. Batterham,et al.  The Gut Hormone Peptide YY Regulates Appetite , 2003, Annals of the New York Academy of Sciences.

[17]  B. Balleine,et al.  The Role of the Dorsal Striatum in Reward and Decision-Making , 2007, The Journal of Neuroscience.

[18]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[19]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[20]  A. Beck‐Sickinger,et al.  Molecular characterization of the ligand–receptor interaction of the neuropeptide Y family , 2000, Journal of peptide science : an official publication of the European Peptide Society.

[21]  William A. Alaynick,et al.  A role for dopamine in feeding responses produced by orexigenic agents , 2004, Brain Research.

[22]  Isabelle Leclerc,et al.  Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  Hisashi Ohta,et al.  Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor , 2011, NeuroImage.

[24]  C. Koebnick,et al.  Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. , 2007, The Journal of clinical endocrinology and metabolism.

[25]  John A Matochik,et al.  Effect of leptin replacement on brain structure in genetically leptin-deficient adults. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  Carol A. Tamminga,et al.  Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia , 2005, Psychiatry Research: Neuroimaging.

[27]  Ji-Kyung Choi,et al.  Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses , 2009, Synapse.

[28]  H Herzog,et al.  XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. , 1998, Pharmacological reviews.

[29]  S. Haber,et al.  Reward-Related Cortical Inputs Define a Large Striatal Region in Primates That Interface with Associative Cortical Connections, Providing a Substrate for Incentive-Based Learning , 2006, The Journal of Neuroscience.

[30]  D. Ffytche,et al.  PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans , 2007, Nature.

[31]  Christoph Beglinger,et al.  Effect of peptide YY3-36 on food intake in humans. , 2005, Gastroenterology.

[32]  K. Wynne,et al.  Attenuated peptide YY release in obese subjects is associated with reduced satiety. , 2006, Endocrinology.

[33]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[34]  J. Wickens,et al.  Neurobiology of ADHD , 2009, Neuropharmacology.

[35]  G. Pelletier,et al.  Role of Neuropeptide Y in the Regulation of Tyrosine Hydroxylase Messenger Ribonucleic Acid Levels in the Male Rat Arcuate Nucleus as Evaluated by in situ Hybridization , 1995, Journal of neuroendocrinology.

[36]  Daniel Grandt,et al.  Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV , 1993, Regulatory Peptides.

[37]  Kevin J. Black,et al.  Dopa-Induced Blood Flow Responses in Nonhuman Primates , 2000, Experimental Neurology.

[38]  P. Hipskind,et al.  Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes 1 , 2003, Experimental biology and medicine.

[39]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[40]  H. Macarthur,et al.  Neuropeptide Y induced modulation of dopamine synthesis in the striatum , 2005, Regulatory Peptides.

[41]  R. Batterham,et al.  Gaining new insights into food reward with functional neuroimaging. , 2010, Forum of nutrition.

[42]  Scott C Matthews,et al.  Demand-specific alteration of medial prefrontal cortex response during an inhibition task in recovered anorexic women. , 2011, The International journal of eating disorders.

[43]  J. Gold,et al.  Caudate Encodes Multiple Computations for Perceptual Decisions , 2010, The Journal of Neuroscience.

[44]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[45]  R. Turner,et al.  Characterizing Dynamic Brain Responses with fMRI: A Multivariate Approach , 1995, NeuroImage.

[46]  David Hevey,et al.  Impaired decision making among morbidly obese adults. , 2011, Journal of psychosomatic research.

[47]  E. Ravussin,et al.  Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Cox,et al.  Peptide YY: A neuroendocrine neighbor of note , 2007, Peptides.

[49]  K. Doya,et al.  A Neural Correlate of Reward-Based Behavioral Learning in Caudate Nucleus: A Functional Magnetic Resonance Imaging Study of a Stochastic Decision Task , 2004, The Journal of Neuroscience.

[50]  Jin Fan,et al.  Common and distinct networks underlying reward valence and processing stages: A meta-analysis of functional neuroimaging studies , 2011, Neuroscience & Biobehavioral Reviews.

[51]  P. Widdowson,et al.  Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain , 1993, Brain Research.

[52]  J M Polak,et al.  Human distribution and release of a putative new gut hormone, peptide YY. , 1985, Gastroenterology.

[53]  Nora D Volkow,et al.  Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.

[54]  Carol A Tamminga,et al.  Functional effects of antipsychotic drugs: comparing clozapine with haloperidol , 2003, Biological Psychiatry.

[55]  Jane E. Joseph,et al.  Prefrontal cortex and drug abuse vulnerability: Translation to prevention and treatment interventions , 2011, Brain Research Reviews.

[56]  David Hevey,et al.  Anorexia, bulimia, and obesity: Shared decision making deficits on the Iowa Gambling Task (IGT) , 2010, Journal of the International Neuropsychological Society.

[57]  E. Borrelli,et al.  Genetically Determined Interaction between the Dopamine Transporter and the D2 Receptor on Prefronto-Striatal Activity and Volume in Humans , 2009, The Journal of Neuroscience.

[58]  A Fournier,et al.  Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. , 1995, The Journal of pharmacology and experimental therapeutics.

[59]  Rita Z. Goldstein,et al.  Inverse Association Between BMI and Prefrontal Metabolic Activity in Healthy Adults , 2009, Obesity.

[60]  P. Mannon,et al.  Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[61]  D. Small,et al.  Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. , 2008, Journal of abnormal psychology.

[62]  Edward T Bullmore,et al.  Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review , 2010, Neuropsychopharmacology.

[63]  K. Black,et al.  Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[65]  C. Gaser,et al.  Partial Volume Segmentation with Adaptive Maximum A Posteriori (MAP) Approach , 2009, NeuroImage.

[66]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[67]  H. Herzog,et al.  Regional distribution of Y‐receptor subtype mRNAs in rat brain , 1999, The European journal of neuroscience.